In a filing, VolitionRX Ltd revealed its 10% Owner Eight Corp Ltd unloaded Company’s shares for reported $18000.0 on Jan 02 ’24. In the deal valued at $0.90 per share,20,000 shares were sold. As a result of this transaction, Eight Corp Ltd now holds 298,419 shares worth roughly $0.25 million.
Then, Butera Salvatore Thomas bought 10,000 shares, generating $8,300 in total proceeds. Upon buying the shares at $0.83, the CEO – Volition Veterinary now owns 99,350 shares.
Before that, Butera Salvatore Thomas bought 10,000 shares. VolitionRX Ltd shares valued at $7,700 were divested by the CEO – Volition Veterinary at a price of $0.77 per share. As a result of the transaction, Butera Salvatore Thomas now holds 89,350 shares, worth roughly $75947.5.
The Benchmark Company downgraded its VolitionRX Ltd [VNRX] rating to a Hold from a a Buy in a research note published recently. Cantor Fitzgerald began covering VNRX with “an Overweight” recommendation on March 10, 2021. Maxim Group started covering the stock on May 16, 2018. It rated VNRX as “a Buy”.
Price Performance Review of VNRX
On Tuesday, VolitionRX Ltd [AMEX:VNRX] saw its stock jump 41.67% to $0.85. Over the last five days, the stock has gained 37.10%. VolitionRX Ltd shares have risen nearly 18.55% since the year began. Nevertheless, the stocks have fallen -51.98% over the past one year. While a 52-week high of $2.10 was reached on 02/06/24, a 52-week low of $0.55 was recorded on 04/19/24. SMA at 50 days reached $0.8601, while 200 days put it at $0.9518. A total of 3.4 million shares were traded, compared to the trading of 51100.0 shares in the previous session.
Levels Of Support And Resistance For VNRX Stock
The 24-hour chart illustrates a support level at 0.6817, which if violated will result in even more drops to 0.5133. On the upside, there is a resistance level at 0.9467. A further resistance level may holdings at 1.0433. The Relative Strength Index (RSI) on the 14-day chart is 59.98, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0014, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 8.20%. Stochastics %K at 42.66% indicates the stock is a holding.
The most recent change occurred on May 14, 2018 when The Benchmark Company resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $5.
